Does EVOLOCUMAB Cause Intercepted product administration error? 2,508 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 2,508 reports of Intercepted product administration error have been filed in association with EVOLOCUMAB (REPATHA). This represents 1.7% of all adverse event reports for EVOLOCUMAB.
2,508
Reports of Intercepted product administration error with EVOLOCUMAB
1.7%
of all EVOLOCUMAB reports
1
Deaths
33
Hospitalizations
How Dangerous Is Intercepted product administration error From EVOLOCUMAB?
Of the 2,508 reports, 1 (0.0%) resulted in death, 33 (1.3%) required hospitalization.
Is Intercepted product administration error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 2,508 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Intercepted product administration error?
DENOSUMAB (1,209)
ERENUMAB-AOOE (1,015)
ETANERCEPT (574)
DARBEPOETIN ALFA (385)
PEGFILGRASTIM (356)
LEUPROLIDE (307)
ERYTHROPOIETIN (301)
ROMOSOZUMAB-AQQG (115)
BENZYL ALCOHOL\ETANERCEPT (112)
CARFILZOMIB (102)
Which EVOLOCUMAB Alternatives Have Lower Intercepted product administration error Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE